Parvovirus B19 infection in pregnancy

Area of Science:

• Virology
• Maternal-Fetal Medicine
• Immunology

Background:

• Parvovirus B19, a single-stranded DNA virus, inhibits erythropoiesis by targeting erythroid progenitor cells.
• Intrauterine parvovirus B19 infection can lead to severe fetal complications like anemia, hydrops fetalis, neurological issues, and fetal demise.

Purpose of the Study:

• To highlight the critical importance of early diagnosis and management of intrauterine parvovirus B19 infection.
• To outline diagnostic methods for maternal and fetal parvovirus B19 infection.
• To discuss current treatment strategies and preventative measures.

Main Methods:

• Maternal infection confirmed by testing serum for IgM antibodies and DNA detection via PCR.
• Fetal anemia and hydrops diagnosed using ultrasound and peak systolic flow velocity of the middle cerebral artery.
• Treatment evaluation including intrauterine transfusion and consideration of delivery induction.

Main Results:

• Parvovirus B19 is a significant threat to fetal well-being during pregnancy.
• Non-invasive fetal monitoring techniques are effective in diagnosing complications.
• Intrauterine transfusion is the primary treatment for fetal anemia.

Conclusions:

• Prompt diagnosis and intervention are essential to prevent severe fetal complications from parvovirus B19.
• Maternal counseling regarding transmission, primarily from infected children, can reduce fetal deaths.
• Integrated management involving maternal testing, fetal surveillance, and appropriate treatment improves outcomes.